2,619
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

Discovery of secondary sulphonamides as IDO1 inhibitors with potent antitumour effects in vivo

ORCID Icon, , , , , , , , , , ORCID Icon, & ORCID Icon show all
Pages 1240-1257 | Received 27 Feb 2020, Accepted 30 Apr 2020, Published online: 28 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Peng-Fei Wang, Li-Qiang Yang, Zhao-Hang Shi, Xue-Min Li & Han-Yue Qiu. (2022) An updated patent review of IDO1 inhibitors for cancer (2018–2022). Expert Opinion on Therapeutic Patents 32:11, pages 1145-1159.
Read now

Articles from other publishers (10)

Thanigaimalai Pillaiyar, Monika Wozniak, Dayana Abboud, Alexander Rasch, Aenne-Dorothea Liebing, Antti Poso, Thales Kronenberger, Claudia Stäubert, Stefan A. Laufer & Julien Hanson. (2023) Development of Ligands for the Super Conserved Orphan G Protein-Coupled Receptor GPR27 with Improved Efficacy and Potency. Journal of Medicinal Chemistry.
Crossref
Romain Amador, Ali Tahrioui, Magalie Barreau, Olivier Lesouhaitier, Michael Smietana & Guillaume Clavé. (2023) N -Acylsulfonamide: a valuable moiety to design new sulfa drug analogues . RSC Medicinal Chemistry 14:8, pages 1567-1571.
Crossref
Yiming Wang, Tianning Huang, Jian Gu & Ling Lu. (2023) Targeting the metabolism of tumor-infiltrating regulatory T cells. Trends in Immunology 44:8, pages 598-612.
Crossref
Trevor W. Stone & Richard O. Williams. (2023) Modulation of T cells by tryptophan metabolites in the kynurenine pathway. Trends in Pharmacological Sciences 44:7, pages 442-456.
Crossref
Farhad Seif, Zahra Torki, Hamidreza Zalpoor, Mehran Habibi & Majid Pornour. (2023) Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives. Molecular Therapy - Oncolytics 28, pages 132-157.
Crossref
Yuheng Yan, Lan Huang, Yiming Liu, Ming Yi, Qian Chu, Dechao Jiao & Kongming Wu. (2022) Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity. Journal of Hematology & Oncology 15:1.
Crossref
Giulia Culletta, Mario Allegra, Anna Maria Almerico, Ignazio Restivo & Marco Tutone. (2022) In Silico Design, Synthesis, and Biological Evaluation of Anticancer Arylsulfonamide Endowed with Anti-Telomerase Activity. Pharmaceuticals 15:1, pages 82.
Crossref
Thanigaimalai Pillaiyar, Francesca Rosato, Monika Wozniak, Jeremy Blavier, Maëlle Charles, Céline Laschet, Thales Kronenberger, Christa E. Müller & Julien Hanson. (2021) Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27. European Journal of Medicinal Chemistry 225, pages 113777.
Crossref
Walter D. Guerra, Daniel Lucena‐Agell, Rafael Hortigüela, Roberto A. Rossi, J. Fernando Díaz, José M. Padrón & Silvia M. Barolo. (2021) Design, Synthesis, and in vitro Evaluation of Tubulin‐Targeting Dibenzothiazines with Antiproliferative Activity as a Novel Heterocycle Building Block . ChemMedChem 16:19, pages 3003-3016.
Crossref
Chan Mo, Shuwen Xie, Bin Liu, Weichao Zhong, Ting Zeng, Sha Huang, Yuqi Lai, Guanghui Deng, Chuying Zhou, Weixin Yan, Yuyao Chen, Shaohui Huang, Lei Gao & Zhiping Lv. (2021) Indoleamine 2,3-dioxygenase 1 limits hepatic inflammatory cells recruitment and promotes bile duct ligation-induced liver fibrosis. Cell Death & Disease 12:1.
Crossref